- Book
- April 2023
- 600 Pages
- Book
- June 2022
- 800 Pages
From €147EUR$165USD£127GBP
- Book
- December 2020
- 400 Pages
From €147EUR$165USD£127GBP
- Report
- January 2023
- 114 Pages
Global
From €3406EUR$3,825USD£2,951GBP
€4008EUR$4,500USD£3,472GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €445EUR$500USD£386GBP
- Report
- October 2023
- 146 Pages
Global
From €3696EUR$4,150USD£3,202GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €445EUR$500USD£386GBP
- Report
- April 2023
- 95 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- June 2023
- 101 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- May 2023
- 105 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- April 2023
- 89 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- March 2022
- 87 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- October 2024
- 99 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- November 2024
- 99 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- November 2024
- 89 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- October 2024
- 101 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- October 2024
- 94 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- October 2024
- 73 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- October 2024
- 83 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Report
- October 2024
- 106 Pages
Global
From €3500EUR$4,210USD£3,139GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more